FDA approves emergency use permission of "antibody cocktail therapy" Trump used this law to treat new crown
Overseas Network, November 22. According to the news from the Russian Satellite News Agency and Reuters, the U.S. Food and Drug Administration (FDA) approved the emergency use license of the "Antibody Cocktail Therapy" of Regeneron Pharmaceuticals.
US President Trump received this treatment during his infection.
The US FDA stated that in clinical trials, the simultaneous use of casirivimab and imdevimab can reduce the number of hospitalizations for new coronary patients and the number of emergency visits for high-risk patients within 28 days. The FDA will continue to evaluate the safety and safety of this exploratory therapy. Effectiveness.
Regeneron Pharmaceuticals of the United States said that the US government will allocate an initial supply of new crown vaccine and is expected to treat approximately 300,000 patients with new crown pneumonia.
According to reports, Trump had previously used the "antibody cocktail therapy" when he was infected with the new coronavirus.
After recovering, Trump praised the drug and promised to quickly approve the drug for the treatment of the new coronavirus.
(Overseas Net Zhang Qi)